{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T16:14:35Z","timestamp":1790180075725,"version":"4.1.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,7,4]],"date-time":"2023-07-04T00:00:00Z","timestamp":1688428800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,7,4]],"date-time":"2023-07-04T00:00:00Z","timestamp":1688428800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Health Qual Life Outcomes"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The increased prevalence of myopia creates and earlier age of onset has created public health concerns for the long-term eye health, vision impairment and carries with it a significant economic burden. The quality of the economic evaluation is dependent on the sensitivity and validity of the approaches. Nowadays, there are many approaches to measure patients\u2019 health state utility (HSU). However, little is known regarding the performance of direct approach and indirect approach in people with myopia. This study is aimed to compare the psychometric properties of four HSU approaches among patients with myopia in mainland China, including two direct approaches (TTO and SG), the generic preference-based measures (PBM) (AQoL-7D) and the disease-specific PBM (VFQ-UI).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A convenience sampling framework was used to recruit patients with myopia who attended a large ophthalmic hospital in Jinan, China. Spearman\u2019s rank correlations coefficient was used to assess concurrent validity. Known-group validity was analyzed by: (1) whether the patients wear corrective devices; (2) severity of myopia as low or moderate to high of the better eye; (3) duration of myopia as\u2009\u2264\u200910\u00a0years or\u2009&gt;\u200910\u00a0years. Effect size (ES), relative efficiency (RE) statistic and the largest area under the receiver operating characteristic curve (AUC) were used to assess sensitivity. The intra-class correlation coefficient (ICC) and Bland\u2013Altman plots were used to assess agreement.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A valid sample size of 477 myopia patients was analyzed (median duration: 10\u00a0years). The mean HSU scores between TTO and SG were similar (0.95) and higher than AQoL-7D (0.89) and VFQ-UI (0.83). Overall, the VFQ-UI had the best performance based on the psychometric analysis. The agreement indicated that there was no pair of approaches that could be used interchangeably.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The VFQ-UI showed better psychometric properties than other three approaches for providing health state utility in Chinese myopia patients. Given the widespread use and its generic nature of the AQoL-7D, it could be used alongside with VFQ-UI to provide complementary health state utility from a generic and disease-specific perspective for economic evaluation. More evidence on the responsiveness of four health utility approaches in myopia patients is required.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12955-023-02150-w","type":"journal-article","created":{"date-parts":[[2023,7,4]],"date-time":"2023-07-04T14:02:25Z","timestamp":1688479345000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Psychometric properties and comparison of four health utility approaches among myopia patients in China"],"prefix":"10.1186","volume":"21","author":[{"given":"Lei","family":"Dou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanjiao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunping","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,4]]},"reference":[{"issue":"12","key":"2150_CR1","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1001\/jamaophthalmol.2016.4008","volume":"134","author":"J Chua","year":"2016","unstructured":"Chua J, Wong TY. Myopia-the silent epidemic that should not be ignored. JAMA Ophthalmol. 2016;134(12):1363\u20134.","journal-title":"JAMA Ophthalmol"},{"issue":"9827","key":"2150_CR2","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1016\/S0140-6736(12)60272-4","volume":"379","author":"IG Morgan","year":"2012","unstructured":"Morgan IG, Ohno-Matsui K, Saw SM. Myopia Lancet. 2012;379(9827):1739\u201348.","journal-title":"Myopia Lancet"},{"issue":"5","key":"2150_CR3","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1016\/j.ophtha.2016.01.006","volume":"123","author":"BA Holden","year":"2016","unstructured":"Holden BA, Fricke TR, Wilson DA, Jong M, Naidoo KS, Sankaridurg P, Wong TY, Naduvilath TJ, Resnikoff S. Global Prevalence of myopia and high Myopia and temporal trends from 2000 through 2050. Ophthalmology. 2016;123(5):1036\u201342.","journal-title":"Ophthalmology"},{"issue":"5","key":"2150_CR4","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1167\/iovs.62.5.2","volume":"62","author":"P Sankaridurg","year":"2021","unstructured":"Sankaridurg P, Tahhan N, Kandel H, Naduvilath T, Zou H, Frick KD, Marmamula S, Friedman DS, Lamoureux E, Keeffe J, et al. IMI impact of Myopia. Invest Ophthalmol Vis Sci. 2021;62(5):2.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2150_CR5","doi-asserted-by":"crossref","unstructured":"Jonas JBL, Wei WB, Wang YX, Jiang WJ H. S. Myopia in China: a population-based cross-sectional, histological, and experimental study. Lancet. 2016;388:S20.","DOI":"10.1016\/S0140-6736(16)31947-X"},{"issue":"1","key":"2150_CR6","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.ajo.2013.08.010","volume":"157","author":"TY Wong","year":"2014","unstructured":"Wong TY, Ferreira A, Hughes R, Carter G, Mitchell P. Epidemiology and disease burden of pathologic myopia and myopic choroidal neovascularization: an evidence-based systematic review. AM J Ophthalmol. 2014;157(1):9\u201325.","journal-title":"AM J Ophthalmol"},{"key":"2150_CR7","first-page":"538","volume":"101","author":"MJ Lipson","year":"2021","unstructured":"Lipson MJ, Boland B, McAlinden C. Vision-related quality of life with Myopia management: a review. Cont Lens Anterior Eye. 2021;101:538.","journal-title":"Cont Lens Anterior Eye"},{"issue":"5","key":"2150_CR8","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/j.ophtha.2018.01.033","volume":"125","author":"BS Modjtahedi","year":"2018","unstructured":"Modjtahedi BS, Ferris FR, Hunter DG, Fong DS. Public health burden and potential interventions for Myopia. Ophthalmology. 2018;125(5):628\u201330.","journal-title":"Ophthalmology"},{"key":"2150_CR9","unstructured":"Brazier J, Ratcliffe J, Salomon JA, Tsuchiya A. Measuring and Valuing Health Benefits for Economic Evaluation. New York: Oxford University Press; 2007."},{"issue":"Supplement","key":"2150_CR10","doi-asserted-by":"publisher","first-page":"S217","DOI":"10.1097\/00005650-198903001-00018","volume":"27","author":"DL Patrick","year":"1989","unstructured":"Patrick DL, Deyo RA. Generic and disease-specific measures in assessing health status and quality of life. MED CARE. 1989;27(Supplement):S217.","journal-title":"MED CARE"},{"key":"2150_CR11","volume-title":"Methods for The Economic Evaluation of Health Care Programmes","author":"MF Drummond","year":"2015","unstructured":"Drummond MF, Sculpher MJ, Torrance GW, O\u2019Brien BJ, Stoddart GL. Methods for The Economic Evaluation of Health Care Programmes. New York: Oxford University Press; 2015."},{"issue":"2","key":"2150_CR12","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/s40258-015-0219-9","volume":"14","author":"E Goodwin","year":"2016","unstructured":"Goodwin E, Green C. A systematic review of the literature on the development of condition-specific preference-based measures of health. Appl Health Econ Health Policy. 2016;14(2):161\u201383.","journal-title":"Appl Health Econ Health Policy"},{"issue":"1","key":"2150_CR13","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.jval.2011.08.002","volume":"15","author":"J Tosh","year":"2012","unstructured":"Tosh J, Brazier J, Evans P, Longworth L. A review of generic preference-based measures of health-related quality of life in visual disorders. Value Health. 2012;15(1):118\u201327.","journal-title":"Value Health"},{"issue":"3","key":"2150_CR14","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.jval.2011.12.003","volume":"15","author":"MM Versteegh","year":"2012","unstructured":"Versteegh MM, Leunis A, Uyl-de GC, Stolk EA. Condition-specific preference-based measures: benefit or burden? Value Health. 2012;15(3):504\u201313.","journal-title":"Value Health"},{"issue":"2","key":"2150_CR15","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1167\/iovs.11-8992","volume":"53","author":"EK Fenwick","year":"2012","unstructured":"Fenwick EK, Xie J, Ratcliffe J, Pesudovs K, Finger RP, Wong TY, Lamoureux EL. The impact of diabetic retinopathy and diabetic macular edema on health-related quality of life in type 1 and type 2 diabetes. Invest Ophthalmol Vis Sci. 2012;53(2):677\u201384.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2150_CR16","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/1471-2415-12-43","volume":"12","author":"FM Bozzani","year":"2012","unstructured":"Bozzani FM, Alavi Y, Jofre-Bonet M, Kuper H. A comparison of the sensitivity of EQ-5D, SF-6D and TTO utility values to changes in vision and perceived visual function in patients with primary open-angle glaucoma. BMC Ophthalmol. 2012;12:43.","journal-title":"BMC Ophthalmol"},{"issue":"8","key":"2150_CR17","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1097\/OPX.0b013e3182962318","volume":"90","author":"T Butt","year":"2013","unstructured":"Butt T, Dunbar HM, Morris S, Orr S, Rubin GS. Patient and public preferences for health states associated with AMD. Optom Vis Sci. 2013;90(8):855\u201360.","journal-title":"Optom Vis Sci"},{"issue":"5","key":"2150_CR18","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1111\/j.1464-5491.2008.02430.x","volume":"25","author":"A Lloyd","year":"2008","unstructured":"Lloyd A, Nafees B, Gavriel S, Rousculp MD, Boye KS, Ahmad A. Health utility values associated with diabetic retinopathy. Diabet Med. 2008;25(5):618\u201324.","journal-title":"Diabet Med"},{"issue":"3","key":"2150_CR19","doi-asserted-by":"publisher","first-page":"172","DOI":"10.3109\/09286586.2012.674613","volume":"19","author":"J Richardson","year":"2012","unstructured":"Richardson J, Iezzi A, Peacock S, Sinha K, Khan M, Misajon R, Keeffe J. Utility weights for the vision-related Assessment of Quality of Life (AQoL)-7D instrument. Ophthalmic Epidemiol. 2012;19(3):172\u201382.","journal-title":"Ophthalmic Epidemiol"},{"issue":"3","key":"2150_CR20","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1001\/jamaophthalmol.2013.7639","volume":"132","author":"AM Rentz","year":"2014","unstructured":"Rentz AM, Kowalski JW, Walt JG, Hays RD, Brazier JE, Yu R, Lee P, Bressler N, Revicki DA. Development of a preference-based index from the National Eye Institute Visual Function Questionnaire-25. JAMA Ophthalmol. 2014;132(3):310\u20138.","journal-title":"JAMA Ophthalmol"},{"issue":"2","key":"2150_CR21","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1177\/0272989X15613522","volume":"36","author":"J Richardson","year":"2016","unstructured":"Richardson J, Iezzi A, Khan MA, Chen G, Maxwell A. Measuring the Sensitivity and Construct Validity of 6 Utility Instruments in 7 Disease Areas. Med Decis Making. 2016;36(2):147\u201359.","journal-title":"Med Decis Making"},{"issue":"3","key":"2150_CR22","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1097\/OPX.0b013e318241720f","volume":"89","author":"AG Malkin","year":"2012","unstructured":"Malkin AG, Goldstein JE, Massof RW. Interpretation of health and vision utilities in low vision patients. Optom Vis Sci. 2012;89(3):288\u201395.","journal-title":"Optom Vis Sci"},{"key":"2150_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9394(99)00146-4","volume-title":"Utility values and diabetic retinopathy","author":"MM Brown","year":"1999","unstructured":"Brown MM, Brown GC, Sharma S, Shah G. Utility values and diabetic retinopathy. 1999."},{"issue":"1","key":"2150_CR24","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1001\/archopht.118.1.47","volume":"118","author":"GC Brown","year":"2000","unstructured":"Brown GC, Sharma S, Brown MM, Kistler J. Utility values and age-related macular degeneration. Arch Ophthalmol. 2000;118(1):47\u201351.","journal-title":"Arch Ophthalmol"},{"issue":"7","key":"2150_CR25","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1097\/OPX.0000000000000299","volume":"91","author":"S Li","year":"2014","unstructured":"Li S, Wang G, Xu Y, Gray A, Chen G. Utility values among myopic patients in mainland China. Optom Vis Sci. 2014;91(7):723\u20139.","journal-title":"Optom Vis Sci"},{"issue":"3","key":"2150_CR26","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1136\/bjo.85.3.327","volume":"85","author":"MM Brown","year":"2001","unstructured":"Brown MM, Brown GC, Sharma S, Kistler J, Brown H. Utility values associated with blindness in an adult population. Brit J ophthalmol. 2001;85(3):327\u201331.","journal-title":"Brit J ophthalmol"},{"issue":"2","key":"2150_CR27","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1097\/OPX.0000000000001327","volume":"96","author":"A Selivanova","year":"2019","unstructured":"Selivanova A, Fenwick E, Man R, Seiple W, Jackson ML. Outcomes After Comprehensive Vision Rehabilitation Using Vision-related Quality of Life Questionnaires: Impact of Vision Impairment and National Eye Institute Visual Functioning Questionnaire. Optom Vis Sci. 2019;96(2):87\u201394.","journal-title":"Optom Vis Sci"},{"issue":"6","key":"2150_CR28","doi-asserted-by":"publisher","first-page":"2878","DOI":"10.1167\/iovs.09-4494","volume":"51","author":"M Marella","year":"2010","unstructured":"Marella M, Pesudovs K, Keeffe JE, O\u2019Connor PM, Rees G, Lamoureux EL. The psychometric validity of the NEI VFQ-25 for use in a low-vision population. Invest Ophthalmol Vis Sci. 2010;51(6):2878\u201384.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2150_CR29","doi-asserted-by":"crossref","unstructured":"Sivaprasad S, Tschosik E, Kapre A, Varma R, Bressler NM, Kimel M, Dolan C, Silverman D. Reliability and Construct Validity of the NEI VFQ-25 in a Subset of Patients With Geographic Atrophy From the Phase 2 Mahalo Study. Am J Ophthalmol. 2018;190:1\u20138.","DOI":"10.1016\/j.ajo.2018.03.006"},{"issue":"7","key":"2150_CR30","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1001\/archopht.119.7.1050","volume":"119","author":"CM Mangione","year":"2001","unstructured":"Mangione CM, Lee PP, Gutierrez PR, Spritzer K, Berry S, Hays RD. Development of the 25-item National Eye Institute Visual Function Questionnaire. Arch Ophthalmol. 2001;119(7):1050\u20138.","journal-title":"Arch Ophthalmol"},{"issue":"2","key":"2150_CR31","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/s11136-011-9938-z","volume":"21","author":"JW Kowalski","year":"2012","unstructured":"Kowalski JW, Rentz AM, Walt JG, Lloyd A, Lee J, Young TA, Chen WH, Bressler NM, Lee P, Brazier JE. Rasch analysis in the development of a simplified version of the national eye institute visual-function questionnaire-25 for utility estimation. Qual Life Res. 2012;21(2):323\u201334.","journal-title":"Qual Life Res"},{"issue":"1","key":"2150_CR32","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1037\/0033-2909.112.1.155","volume":"112","author":"J Cohen","year":"1992","unstructured":"Cohen J. A power primer. Psychol Bull. 1992;112(1):155\u20139.","journal-title":"Psychol Bull"},{"key":"2150_CR33","doi-asserted-by":"publisher","first-page":"b2688","DOI":"10.1136\/bmj.b2688","volume":"339","author":"D Arnold","year":"2009","unstructured":"Arnold D, Girling A, Stevens A, Lilford R. Comparison of direct and indirect methods of estimating health state utilities for resource allocation: review and empirical analysis. BMJ. 2009;339:b2688.","journal-title":"BMJ"},{"issue":"3","key":"2150_CR34","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1136\/bjo.87.3.341","volume":"87","author":"SM Saw","year":"2003","unstructured":"Saw SM, Gazzard G, Au EK, Koh D. Utility values and myopia in teenage school students. Br J Ophthalmol. 2003;87(3):341\u20135.","journal-title":"Br J Ophthalmol"},{"issue":"4","key":"2150_CR35","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1097\/01.OPX.0000159370.66540.34","volume":"82","author":"F Thorn","year":"2005","unstructured":"Thorn F, Gwiazda J, Held R. Myopia progression is specified by a double exponential growth function. Optom Vis Sci. 2005;82(4):286\u201397.","journal-title":"Optom Vis Sci"},{"issue":"1","key":"2150_CR36","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1097\/MLR.0b013e31817d92f8","volume":"47","author":"N Luo","year":"2009","unstructured":"Luo N, Johnson JA, Shaw JW, Coons SJ. Relative efficiency of the EQ-5D, HUI2, and HUI3 index scores in measuring health burden of chronic medical conditions in a population health survey in the United States. Med Care. 2009;47(1):53\u201360.","journal-title":"Med Care"},{"issue":"4857","key":"2150_CR37","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1126\/science.3287615","volume":"240","author":"JA Swets","year":"1988","unstructured":"Swets JA. Measuring the accuracy of diagnostic systems. Science. 1988;240(4857):1285\u201393.","journal-title":"Science"},{"issue":"1","key":"2150_CR38","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.jclinepi.2006.03.012","volume":"60","author":"CB Terwee","year":"2007","unstructured":"Terwee CB, Bot SD, de Boer MR, van der Windt DA, Knol DL, Dekker J, Bouter LM, de Vet HC. Quality criteria were proposed for measurement properties of health status questionnaires. J Clin Epidemiol. 2007;60(1):34\u201342.","journal-title":"J Clin Epidemiol"},{"issue":"4","key":"2150_CR39","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1037\/1040-3590.6.4.284","volume":"6","author":"V Cicchetti Domenic","year":"1994","unstructured":"Cicchetti Domenic V. Guidelines, Criteria, and Rules of Thumb for Evaluating Normed and Standardized Assessment Instruments in Psychology. Psychol Assessment. 1994;6(4):284\u201390.","journal-title":"Psychol Assessment"},{"key":"2150_CR40","unstructured":"Rosner BA. The intraclass correlation coefficient. In: Fundamentals of biostatistics.\u00a0Boston: Harvard University; 2011."},{"key":"2150_CR41","volume-title":"Basic Biostatistics Statistics for Public Health Practice","author":"BB Gerstman","year":"2008","unstructured":"Gerstman BB. Basic Biostatistics: Statistics for Public Health Practice. In: Basic Biostatistics Statistics for Public Health Practice. 2nd ed. 2008.","edition":"2nd"},{"issue":"8476","key":"2150_CR42","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/S0140-6736(86)90837-8","volume":"1","author":"JM Bland","year":"1986","unstructured":"Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986;1(8476):307\u201310.","journal-title":"Lancet"},{"issue":"2","key":"2150_CR43","doi-asserted-by":"publisher","first-page":"160","DOI":"10.2188\/jea.12.160","volume":"12","author":"T Morimoto","year":"2002","unstructured":"Morimoto T, Fukui T. Utilities measured by rating scale, time trade-off, and standard gamble: review and reference for health care professionals. J Epidemiol. 2002;12(2):160\u201378.","journal-title":"J Epidemiol"},{"issue":"8","key":"2150_CR44","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1001\/jamaoto.2015.1314","volume":"141","author":"CW Noel","year":"2015","unstructured":"Noel CW, Lee DJ, Kong Q, Xu W, Simpson C, Brown D, Gilbert RW, Gullane PJ, Irish JC, Huang SH, et al. Comparison of health state utility measures in patients with head and neck cancer. JAMA Otolaryngol Head Neck Surg. 2015;141(8):696\u2013703.","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"issue":"5","key":"2150_CR45","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/S0895-4356(99)00205-X","volume":"53","author":"M Hanita","year":"2000","unstructured":"Hanita M. Self-report measures of patient utility: should we trust them? J Clin Epidemiol. 2000;53(5):469\u201376.","journal-title":"J Clin Epidemiol"},{"issue":"9 Suppl","key":"2150_CR46","first-page":"I160","volume":"38","author":"J Tsevat","year":"2000","unstructured":"Tsevat J. What do utilities measure? Med Care. 2000;38(9 Suppl):I160\u20134.","journal-title":"Med Care"},{"issue":"7","key":"2150_CR47","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1136\/bjophthalmol-2011-301201","volume":"96","author":"RP Finger","year":"2012","unstructured":"Finger RP, Hoffmann AE, Fenwick EK, Wolf A, Kampik A, Kernt M, Neubauer AS, Hirneiss C. Patients\u2019 preferences in treatment for neovascular age-related macular degeneration in clinical routine. Br J Ophthalmol. 2012;96(7):997\u20131002.","journal-title":"Br J Ophthalmol"},{"issue":"5","key":"2150_CR48","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1007\/s11136-018-1819-2","volume":"27","author":"L Liu","year":"2018","unstructured":"Liu L, Li S, Zhao Y, Zhang J, Chen G. Health state utilities and subjective well-being among psoriasis vulgaris patients in mainland China. Qual Life Res. 2018;27(5):1323\u201333.","journal-title":"Qual Life Res"},{"issue":"1","key":"2150_CR49","first-page":"231","volume":"19","author":"JP Weir","year":"2005","unstructured":"Weir JP. Quantifying test-retest reliability using the intraclass correlation coefficient and the SEM. J Strength Cond Res. 2005;19(1):231\u201340.","journal-title":"J Strength Cond Res"},{"issue":"3","key":"2150_CR50","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1037\/0033-2909.93.3.586","volume":"93","author":"MA Lahey","year":"1983","unstructured":"Lahey MA, Downey RG, Saal FE. Intraclass correlations: There\u2019s more there than meets the eye. Psychol Bull. 1983;93(3):586\u201395.","journal-title":"Psychol Bull"},{"issue":"5","key":"2150_CR51","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1007\/s11136-021-03047-1","volume":"31","author":"Y Si","year":"2022","unstructured":"Si Y, Li S, Xu Y, Chen G. Validation and comparison of five preference-based measures among age-related macular degeneration patients: evidence from mainland China. Qual Life Res. 2022;31(5):1561\u201372.","journal-title":"Qual Life Res"},{"issue":"7","key":"2150_CR52","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1097\/00005650-200307000-00003","volume":"41","author":"B Conner-Spady","year":"2003","unstructured":"Conner-Spady B, Suarez-Almazor ME. Variation in the estimation of quality-adjusted life-years by different preference-based instruments. Med Care. 2003;41(7):791\u2013801.","journal-title":"Med Care"},{"issue":"10","key":"2150_CR53","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1097\/IJG.0000000000000441","volume":"25","author":"RL Goh","year":"2016","unstructured":"Goh RL, Fenwick E, Skalicky SE. The visual function questionnaire: utility index: does it measure glaucoma-related preference-based status? J Glaucoma. 2016;25(10):822\u20139.","journal-title":"J Glaucoma"},{"issue":"11","key":"2150_CR54","doi-asserted-by":"publisher","first-page":"4818","DOI":"10.1167\/iovs.17-21945","volume":"58","author":"J Brazier","year":"2017","unstructured":"Brazier J, Muston D, Konwea H, Power GS, Barzey V, Lloyd A, Sowade O, Vitti B, Gerlinger C, Roberts J. Evaluating the relationship between visual acuity and utilities in patients with diabetic macular edema enrolled in intravitreal aflibercept studies. Invest Ophthalmol Vis Sci. 2017;58(11):4818\u201325.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"Suppl 1","key":"2150_CR55","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s40273-017-0546-9","volume":"35","author":"D Rowen","year":"2017","unstructured":"Rowen D, Brazier J, Ara R, Azzabi ZI. The role of condition-specific preference-based measures in health technology assessment. Pharmacoeconomics. 2017;35(Suppl 1):33\u201341.","journal-title":"Pharmacoeconomics"}],"container-title":["Health and Quality of Life Outcomes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12955-023-02150-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12955-023-02150-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12955-023-02150-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,4]],"date-time":"2023-07-04T15:40:58Z","timestamp":1688485258000},"score":1,"resource":{"primary":{"URL":"https:\/\/hqlo.biomedcentral.com\/articles\/10.1186\/s12955-023-02150-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,4]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2150"],"URL":"https:\/\/doi.org\/10.1186\/s12955-023-02150-w","relation":{},"ISSN":["1477-7525"],"issn-type":[{"value":"1477-7525","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,4]]},"assertion":[{"value":"21 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethics Review Board of the School of Public Health, Shandong University (Reference No.20141002). The patients\/participants were voluntary and provided written informed consent to participate in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors understand and agree to publish.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"66"}}